Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son

Annals of the Rheumatic Diseases

Volumn 64, Issue 6, 2005, Pages 845-848

  Lambert, Nathalie C ^a,b   Pang, J M ^b   Yan, Z ^b   Erickson, T D ^b   Stevens, A M ^c   Furst, D E ^d   Nelson, J L ^b  

^a TIMONE HOSPITAL   (France)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOME; HUMAN; INDUCED ABORTION; MICROCHIMERISM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC SCLEROSIS; Y CHROMOSOME;

EID: 19544392163     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.029314     Document Type: Article

References (14)

1. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996;88:4390-5.
2. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1990;93:705-8.
3. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999;104:41-7.
4. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559-62.
5. De Moor G, De Bock G, Noens L, De Bie S. A new case of human chimerism detected after pregnancy: 46,XY karyotype in the lymphocytes of a woman. Acta Clin Belg 1988;43:231-5.
6. Bianchi DW, Farina A, Weber W, Delli-Bovi LC, Deriso M, Williams JM, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001;184:703-6.
7. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
8. Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002;100:2845-51.
9. Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 2004;50:906-14.
10. Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun Rev 2003;2:133-9.
11. Diamond JM. Causes of death before birth. Nature 1987;329:487-8.
12. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003;48:3237-41.
13. Robinson HP, Caines JS. Sonar evidence of early pregnancy failure in patients with twin conceptions. Br J Obstet Gynaecol 1977;84:22-5.
14. Gannage M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S. Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol 2002;32:3405-13.